KETAMINE HCL

Pre-Launch

ketamine hydrochloride

ANDAInjectionInjectable

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

KETAMINE HCL (ketamine hydrochloride) by Baxter is injection, a racemic mixture of ketamine, is a non-selective, non-competitive antagonist of the n-methyl-d-aspartate (nmda) receptor, an ionotropic glutamate receptor.

Drug data last refreshed 1mo ago

See 10 jobs working on KETAMINE HCL →

Mechanism of Action

injection, a racemic mixture of ketamine, is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. The major circulating metabolite of ketamine (norketamine) demonstrated activity at the same receptor with less affinity.…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Why This Matters for Your Career

Baxter is hiring 10 roles related to this product

Worked on KETAMINE HCL at Baxter? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.